Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass

PHASE4CompletedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

July 16, 2016

Study Completion Date

October 31, 2017

Conditions
Iron Deficiency Anemia Secondary to IBD or Gastric Bypass
Interventions
DRUG

Injectafer

2 doses of Injectafer, at 15mg/kg for a maximum single dose of 750mg given on days 0 and 7 for a total of up to 1500mg

DRUG

Ferrous Sulfate tablets

325mg (1 tablet) three times a day for 28 days

Sponsors
All Listed Sponsors
lead

American Regent, Inc.

INDUSTRY

NCT02086968 - Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass | Biotech Hunter | Biotech Hunter